Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial.
第一作者:
Toshihiro,Kudo
第一单位:
Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Osaka, Japan.
作者:
医学主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);厌食(Anorexia);抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤药(Antineoplastic Agents);癌, 鳞状细胞(Carcinoma, Squamous Cell);脱水(Dehydration);呼吸困难(Dyspnea);食管肿瘤(Esophageal Neoplasms);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);低钠血症(Hyponatremia);肺疾病(Lung Diseases);男(雄)性(Male);中年人(Middle Aged);再治疗(Retreatment)
DOI
10.1016/S1470-2045(17)30181-X
PMID
28314688
发布时间
2022-11-09
- 浏览27
The Lancet. Oncology
631-639页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



